Synaptrix

Synaptrix

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.5M

Overview

Synaptrix Labs is an early-stage biotech company pioneering next-generation, non-invasive brain-computer interfaces (BCIs) powered by proprietary AI. Its initial focus is on assistive technology, with the Neuralis system aiming to restore mobility for paralyzed individuals through thought-controlled wheelchairs. The company is also developing a broader AI platform, NeuroDiffusion, for EEG/EMG signal processing and is exploring other applications like EMG-to-text communication. Currently in the clinical trial recruitment phase for Neuralis, Synaptrix has gained recognition through various startup competitions and accelerator programs like Nvidia Inception.

NeurologyAssistive Technology

Technology Platform

Proprietary AI-based EEG/EMG signal processing platform, featuring the NeuroDiffusion™ de-noising API, designed to enable high-performance non-invasive brain-computer interfaces.

Funding History

1
Total raised:$4.5M
Seed$4.5M

Opportunities

The immediate opportunity lies in addressing the unmet need for intuitive assistive mobility technology for the paralyzed population.
Long-term, the company's AI platform could be leveraged across a wide spectrum of neurological diagnostics, rehabilitation, and consumer neurotech applications, tapping into a multi-billion dollar market.

Risk Factors

Key risks include the formidable technical challenge of creating a reliable non-invasive BCI, the lengthy and uncertain clinical/regulatory pathway for medical devices, and strong competition from other neurotech startups and established players.
As a pre-revenue startup, execution and funding risks are also significant.

Competitive Landscape

Synaptrix operates in the competitive neurotech and BCI space, facing rivals like Synchron and Paradromics (invasive BCIs) as well as other non-invasive companies such as NextMind (acquired by Snap) and open-source projects like OpenBCI. Its differentiation hinges on the claimed superior performance of its AI-driven, non-invasive signal processing platform.